Global Needle Free Injection Systems Market Companies

The market is segmented based on , By Type (Liquid-Based Needle-Free Injectors, Projectile/Depot-Based Needle-Free Injectors, Powder-Based Needle Free Injectors), Product (Fillable Needle-Free Injectors, Prefilled Needle-Free Injectors), Technology (Jet-Based Needle-Free Injectors, Spring Global Needle Free Injectors, Laser-Powered Needle-Free Injectors,  Vibration-Based Needle-Free Injectors), Usability (Disposable Needle-Free Injectors, Reusable Needle-Free Injectors), Site of Delivery (Subcutaneous Injectors, Intramuscular Injectors, Intradermal Injectors), Application (Vaccine Delivery, Insulin Delivery, Oncology, Pain Management, Other), End User (Hospitals and Clinics, Home Care Settings, Research Laboratories, Pharmaceutical and Biotechnological Companies, Other) - Industry Trends and Forecast to 2030. .

The Global Needle Free Injection Systems Market size was valued at USD 156.00 USD Million in 2022.

The Global Needle Free Injection Systems Market is projected to grow at a CAGR of 20% during the forecast period of 2023 to 2030.

The major players operating in the market include PharmaJet , Portal Instruments , Medical International TechnologyInc , NuGen Medical Devices , Crossject SA , Antares Pharma , 3M , Injex Pharma AG, NovaXS Biotech and INVIO Pharmaceutical Inc. .

The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.